Proteasome inhibitors
Bortezomib
The FDA lists this product in 34 strengths and forms.
Composition
- Active ingredients
- BORTEZOMIB 3.5MG/1.4ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- BORTEZOMIB 3.5MG/VIAL · InjectableANDA208460-001 · Prescription
- BORTEZOMIB 1MG/VIAL · PowderNDA209191-001 · Prescription
- BORTEZOMIB 2.5MG/VIAL · PowderNDA209191-002 · Prescription
- BORTEZOMIB 3.5MG/VIAL · InjectableANDA210204-001 · Prescription
- BORTEZOMIB 3.5MG/VIAL · InjectableANDA203654-001 · Discontinued
- BORTEZOMIB 3.5MG/VIAL · InjectableANDA205533-001 · Prescription
- BORTEZOMIB 3.5MG/1.4ML · InjectableThis page
- BORTEZOMIB 2.5MG/ML · InjectableNDA208645-001 · Tentative approval
- BORTEZOMIB 3.5MG/VIAL · InjectableANDA209622-001 · Prescription
- BORTEZOMIB 3.5MG/VIAL · InjectableANDA210824-001 · Prescription
- BORTEZOMIB 3.5MG/VIAL · InjectableANDA218688-001 · Prescription
- BORTEZOMIB 3.5MG/VIAL · InjectableANDA208392-001 · Prescription
- BORTEZOMIB 3.5MG/1.4ML (2.5MG/ML) · SolutionNDA212782-001 · Prescription
At a glance
- Brand name
- Bortezomib
- Drug class
- Proteasome inhibitors
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Actavis LLC
- Status
- Tentative approval
- FDA approval
- 20 Oct 2016
- Application
- NDA208645-002
- RxCUI
- 358258